Maarten Cozijnsen

90 Supplementary table 1. Continued Protein Infliximab treated patients Prednisolone treated patients Fold change (mean) False discovery rate Fold change (mean) False discovery rate Signaling lymphocytic activation molecule (SLAMF1) -0.29 0.076 -0.46 0.350 Transforming growth factor alpha (TGF-alpha) -2.01 0.076 -0.98 0.410 Tumor necrosis factor ligand superfamily member 14 (TNFSF14) -1.53 0.076 -0.59 0.350 Tumor necrosis factor (Ligand) superfamily, member 12 (TWEAK) -0.45 0.076 -0.23 0.708 Vascular endothelial growth factor A (VEGF-A) -1.32 0.076 -0.60 0.350 Axin-1 (AXIN1) -0.77 0.101 0.09 0.708 C-C motif chemokine 20 (CCL20) -1.26 0.101 -0.25 0.799 T cell surface glycoprotein CD6 isoform (CD6) -0.34 0.101 -0.28 0.350 Fms-related tyrosine kinase 3 ligand (Flt3L) 0.86 0.101 0.51 0.635 Interleukin-10 receptor subunit beta (IL-10RB) -0.34 0.101 0.06 0.799 Matrix metalloproteinase-10 (MMP-10) -0.55 0.101 -0.69 0.410 SIR2-like protein 2 (SIRT2) -0.80 0.101 1.29 0.350 TNF-beta (TNFB) -0.25 0.101 -0.06 0.903 Tumor necrosis factor (TNF) -0.08 0.124 0.14 0.708 Eotaxin-1 (CCL11) -0.62 0.144 -0.19 0.799 Interleukin-15 receptor subunit alpha (IL-15RA) -0.25 0.144 0.02 0.799 Interleukin-17C (IL-17C) -0.64 0.144 -0.09 0.635 Interleukin-24 (IL-24) -0.62 0.144 -0.49 0.350 Stem cell factor (SCF) 0.51 0.144 0.43 0.635 STAM-binding protein (STAMPB) -0.48 0.175 1.28 0.350 Beta-nerve growth factor (Beta-NGF) -0.22 0.187 -0.04 0.903 Cystatin D (CST5) 0.36 0.187 0.15 0.635 C-X-C motif chemokine 6 (CXCL6) -0.52 0.187 -0.19 0.708 Fibroblast growth factor 21 (FGF-21) -1.36 0.187 -0.22 0.903 Interleukin-1 alpha (IL-1 alpha) 0.07 0.187 -0.35 0.799 Interleukin-2 receptor subunit beta (IL-2RB) -0.35 0.187 -0.35 0.531 Monocyte chemotactic protein 1 (MCP-1) -0.41 0.187 0.02 0.903 Monocyte chemotactic protein 2 (MCP-2) -0.36 0.187 0.05 0.799 C-C motif chemokine 28 (CCL28) -0.35 0.215 -0.12 0.708 Fibroblast growth factor 19 (FGF-19) 0.81 0.215 0.53 0.410